Goldman Sachs’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.84M | Buy |
523,416
+326,348
| +166% | +$4.89M | ﹤0.01% | 2452 |
|
|
2025
Q1 | $3.18M | Sell |
197,068
-550,484
| -74% | -$8.88M | ﹤0.01% | 3060 |
|
|
2024
Q4 | $17.4M | Buy |
747,552
+578,238
| +342% | +$13.5M | ﹤0.01% | 1896 |
|
|
2024
Q3 | $4.98M | Sell |
169,314
-723,769
| -81% | -$21.3M | ﹤0.01% | 2762 |
|
|
2024
Q2 | $21M | Buy |
893,083
+653,168
| +272% | +$15.4M | ﹤0.01% | 1570 |
|
|
2024
Q1 | $9.1M | Buy |
+239,915
| New | +$9.1M | ﹤0.01% | 2119 |
|
|
2023
Q3 | – | Sell |
-22,346
| Closed | -$252K | – | 4933 |
|
|
2023
Q2 | $252K | Buy |
+22,346
| New | +$252K | ﹤0.01% | 4313 |
|
|
2022
Q4 | – | Sell |
-36,628
| Closed | -$482K | – | 5345 |
|
|
2022
Q3 | $482K | Sell |
36,628
-10,864
| -23% | -$143K | ﹤0.01% | 4274 |
|
|
2022
Q2 | $600K | Buy |
47,492
+2,500
| +6% | +$31.6K | ﹤0.01% | 4262 |
|
|
2022
Q1 | $2.59M | Sell |
44,992
-382
| -0.8% | -$22K | ﹤0.01% | 3358 |
|
|
2021
Q4 | $5.39M | Sell |
45,374
-68
| -0.1% | -$8.08K | ﹤0.01% | 2741 |
|
|
2021
Q3 | $9.03M | Buy |
45,442
+200
| +0.4% | +$39.7K | ﹤0.01% | 2353 |
|
|
2021
Q2 | $7.87M | Sell |
45,242
-225
| -0.5% | -$39.2K | ﹤0.01% | 2436 |
|
|
2021
Q1 | $9M | Buy |
45,467
+28,078
| +161% | +$5.56M | ﹤0.01% | 2281 |
|
|
2020
Q4 | $3.42M | Sell |
17,389
-520
| -3% | -$102K | ﹤0.01% | 2715 |
|
|
2020
Q3 | $3.17M | Sell |
17,909
-280
| -2% | -$49.6K | ﹤0.01% | 2662 |
|
|
2020
Q2 | $4.21M | Buy |
18,189
+1,326
| +8% | +$307K | ﹤0.01% | 2436 |
|
|
2020
Q1 | $1.97M | Sell |
16,863
-819
| -5% | -$95.4K | ﹤0.01% | 2770 |
|
|
2019
Q4 | $3.38M | Buy |
17,682
+282
| +2% | +$53.9K | ﹤0.01% | 2646 |
|
|
2019
Q3 | $3.35M | Buy |
17,400
+1,557
| +10% | +$299K | ﹤0.01% | 2554 |
|
|
2019
Q2 | $2.71M | Sell |
15,843
-294
| -2% | -$50.3K | ﹤0.01% | 2645 |
|
|
2019
Q1 | $3.25M | Buy |
16,137
+15,430
| +2,182% | +$3.11M | ﹤0.01% | 2678 |
|
|
2018
Q4 | $132K | Sell |
707
-59
| -8% | -$11K | ﹤0.01% | 3844 |
|
|
2018
Q3 | $183K | Buy |
766
+80
| +12% | +$19.1K | ﹤0.01% | 3835 |
|
|
2018
Q2 | $181K | Buy |
686
+210
| +44% | +$55.4K | ﹤0.01% | 3897 |
|
|
2018
Q1 | $118K | Buy |
+476
| New | +$118K | ﹤0.01% | 3984 |
|
|
2017
Q1 | – | Sell |
-415
| Closed | -$45K | – | 4535 |
|
|
2016
Q4 | $45K | Sell |
415
-906
| -69% | -$98.2K | ﹤0.01% | 4241 |
|
|
2016
Q3 | $212K | Sell |
1,321
-928
| -41% | -$149K | ﹤0.01% | 3898 |
|
|
2016
Q2 | $273K | Buy |
+2,249
| New | +$273K | ﹤0.01% | 3684 |
|